FIBROBIOLOGICS INC. - COMMON STOCK

FibroBiologics Presenting at the ThymUS 2025 Meeting

29 Apr 2025 09:15:00 By Nasdaq GlobeNewswire

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

11 Apr 2025 08:30:00 By Nasdaq GlobeNewswire

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

08 Apr 2025 08:30:00 By Nasdaq GlobeNewswire

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

02 Apr 2025 08:30:00 By Nasdaq GlobeNewswire

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

31 Mar 2025 16:25:00 By Nasdaq GlobeNewswire

FibroBiologics Announces 2025 Annual Meeting of Stockholders

27 Mar 2025 08:30:00 By Nasdaq GlobeNewswire

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

21 Mar 2025 08:30:00 By Nasdaq GlobeNewswire

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

04 Mar 2025 08:30:00 By Nasdaq GlobeNewswire

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

27 Feb 2025 08:30:00 By Nasdaq GlobeNewswire

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

05 Feb 2025 09:15:00 By Nasdaq GlobeNewswire

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

30 Dec 2024 16:30:00 By Nasdaq GlobeNewswire

FibroBiologics Announces $25 Million Financing

23 Dec 2024 07:55:00 By Nasdaq GlobeNewswire

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

19 Nov 2024 09:15:00 By Nasdaq GlobeNewswire

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

14 Nov 2024 09:15:00 By Nasdaq GlobeNewswire

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

12 Nov 2024 16:20:00 By Nasdaq GlobeNewswire

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

29 Oct 2024 09:15:00 By Nasdaq GlobeNewswire

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

28 Oct 2024 09:31:00 By Nasdaq GlobeNewswire

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

18 Oct 2024 08:30:00 By Nasdaq GlobeNewswire

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

16 Oct 2024 09:15:00 By Nasdaq GlobeNewswire

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

11 Oct 2024 09:31:00 By Nasdaq GlobeNewswire